| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/31/1992 | CA1298294C Pyrrole derivatives, their preparation and their pharmaceutical compositions therein |
| 03/31/1992 | CA1298201C Method and compositions for treating obesity, depression, drug abuse and narcolepsy |
| 03/31/1992 | CA1298200C Process for producing a synergistic combination of amantadine and selegiline |
| 03/31/1992 | CA1298199C Spray dried acetaminophen |
| 03/31/1992 | CA1298198C Composition comprising l-dopa |
| 03/31/1992 | CA1298197C Use of acetyl l-carnitine in the therapeutical treatment of peripheral neuropathies |
| 03/29/1992 | WO1992005783A1 Ibuprofen-antihistamine combinations |
| 03/29/1992 | CA2092566A1 Ibuprofen-antihistamine combinations |
| 03/27/1992 | CA2052234A1 Heterocyclic alkyl amines, process for their preparation and pharmaceutical compositions holding same |
| 03/25/1992 | EP0477049A1 Amido-3-pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/25/1992 | EP0476933A1 Neurotrophic peptide derivatives |
| 03/25/1992 | EP0476233A1 Human MK gene and protein sequence |
| 03/25/1992 | EP0476016A1 Therapeutically useful 2-aminotetralin derivatives |
| 03/25/1992 | CN1059724A Tricyclic compounds |
| 03/25/1992 | CN1059722A 3-aryl-4(3h) quinazolinone cck antagonists and pharmaceutical formulations thereof |
| 03/25/1992 | CN1059717A Serotonin 5htia agonists |
| 03/25/1992 | CN1015987B Preparation method of bridged two-rings dicarboximide compound used for anti-worries and anti-depression drug |
| 03/25/1992 | CN1015982B Novel bicyclic lactam pharmacologically active compositions thereof process for the preparation thereof and their medical use |
| 03/24/1992 | US5098934 Method of relieving pain with mercaptoalkanamides |
| 03/24/1992 | US5098925 Neurological disorders in mammals |
| 03/24/1992 | US5098922 Anticonvulsants |
| 03/24/1992 | US5098916 Central nervous system as antiischemic agents, dystonia and as anticonvulsants |
| 03/24/1992 | US5098904 Cerebral function enhancing pyrimidinyl derivatives |
| 03/24/1992 | US5098889 Cognition activators, angiotensin converting enzyme inhibitors |
| 03/24/1992 | US5098888 Cholinergic agents and antispasmodic agents |
| 03/24/1992 | CA1297909C 1-(aminophenyl)-2-aminoethanone derivatives, the method for their preparation and their use in therapy |
| 03/24/1992 | CA1297877C Benzofurancarboxamides useful as antiemetic or antipsychotic agents |
| 03/19/1992 | WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
| 03/19/1992 | WO1992004350A1 Oxygenated quinoxalines |
| 03/19/1992 | WO1992004345A1 6- or 7- (2-IMINO-2-IMIDAZOLIDINE)-1,4-BENZOXAZINES AS ALPHA ADRENERGIC AGENTS |
| 03/19/1992 | WO1992004323A1 1,2,5,6-tetrahydropyridine oxime derivatives |
| 03/19/1992 | WO1992004316A1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 03/19/1992 | WO1992004045A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
| 03/19/1992 | WO1992004038A1 Pro-drugs for cck antagonists |
| 03/19/1992 | WO1992004036A1 Kava extract, method of preparing the extract, and its use |
| 03/19/1992 | WO1992004018A1 Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals |
| 03/19/1992 | WO1992004008A1 Composition for treating ocular pain |
| 03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
| 03/19/1992 | DE4028945A1 Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung Kava-kava extract, process for its preparation and its use |
| 03/19/1992 | CA2088195A1 Cholecystokinin antagonists, their preparation and therapeutic use |
| 03/19/1992 | CA2073003A1 Composition for treating ocular pain |
| 03/18/1992 | WO1992004897A1 1-substituted phenoxathiin derivatives as antidepressants |
| 03/18/1992 | EP0475844A1 Use of N-(1.hexahydroazepinylalkyl) acetamides for the manufacture of medicaments for the treatment of disorders of the cholineogic transmission |
| 03/18/1992 | EP0475755A1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof |
| 03/18/1992 | EP0475352A1 3-(1H-Indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
| 03/18/1992 | EP0475187A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia |
| 03/18/1992 | EP0474979A1 Heparin binding neurotrophic factor gene sequence |
| 03/18/1992 | CN1059517A Acetamide derivatives |
| 03/18/1992 | CN1015892B Process for preparing a new derivative of an aminoketone |
| 03/18/1992 | CA2091685A1 1-substituted phenoxathiin derivatives as antidepressants |
| 03/18/1992 | CA2050043A1 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/18/1992 | CA2050042A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/18/1992 | CA2049506A1 Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 03/17/1992 | US5096926 Injectable formulations containing the sodium salt of naproxen |
| 03/17/1992 | US5096902 Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical compositions containing them and process for preparing same |
| 03/17/1992 | US5096901 Pharmacologically active amides and esters containing an azabicycloalkane moiety |
| 03/17/1992 | US5096890 Pyrrolidine derivatives |
| 03/17/1992 | US5096712 Administering tyrosine and synergistic indirect-acting sympathomimetic drug |
| 03/17/1992 | CA1297492C Antagonists of specific excitatory amino acid neurotransmitter receptors |
| 03/17/1992 | CA1297408C Bioadhesive extruded film for intra-oral drug delivery and process |
| 03/15/1992 | CA2051007A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia |
| 03/14/1992 | WO1992005172A2 Muscarinic receptor antagonists |
| 03/14/1992 | CA2091246A1 Indole ureas as 5 ht receptor antagonist |
| 03/14/1992 | CA2068527A1 Muscarinic receptor antagonists |
| 03/14/1992 | CA2050994A1 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof |
| 03/13/1992 | CA2051157A1 Neurotrophic peptide derivatives |
| 03/13/1992 | CA2051091A1 Utilization of n-(1-hexahydroazepinylalkyl)acetamides for preparing drugs used for treating cholinergic transmission troubles |
| 03/12/1992 | WO1992004021A1 Method for providing improved analgesic effect |
| 03/12/1992 | DE4028398A1 Phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung Phenylethanolamine, pharmaceutical compositions containing them and methods for their manufacture |
| 03/11/1992 | WO1992004321A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 03/11/1992 | WO1992004040A1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
| 03/11/1992 | EP0474597A2 Diphenyl compounds as inhibitors of the arachidonic acid pathway and their use in pharmaceutical compositions |
| 03/11/1992 | EP0474580A2 Use of 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders |
| 03/11/1992 | EP0474012A1 6,7-Dihydro-3-phenyl-1,2-benzisoxazol-4(5H)-ones and -ols, a process for their preparation and their use as medicaments |
| 03/11/1992 | EP0473671A1 Use of sigma-receptors ligands for the manufacture of an anxiolytic agent. |
| 03/11/1992 | EP0473604A1 Onset-hastened/enhanced antipyretic response |
| 03/11/1992 | CA2091257A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity |
| 03/10/1992 | US5095039 Diphenylsulfide compound and use |
| 03/10/1992 | US5095018 Anticonvulsants |
| 03/10/1992 | US5095015 G-aminobutyric acid, anticonvulsants, tranquilizers, sleep disorders |
| 03/10/1992 | US5095014 3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having anticonvulsant activity |
| 03/10/1992 | CA1297111C .alpha.-ALKYL-4-AMINO-3-QUINOLINEMETHANOLS AND 1-(4- ARALKYL-AMINO-3-QUINOLINYL)ALKANONES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 03/10/1992 | CA1297105C Amino acid derivatives |
| 03/10/1992 | CA1297099C Quinazoline compounds and their preparation and use |
| 03/10/1992 | CA1297036C Method for treating depression with d-fenfluramine |
| 03/08/1992 | WO1992004371A1 Kininogenase inhibitors |
| 03/08/1992 | WO1992004310A1 Triarylethylene carboxylic acids with estrogenic activity |
| 03/08/1992 | CA2090858A1 Kininogenase inhibitors |
| 03/08/1992 | CA2089373A1 Triarylethylene carboxylic acids with estrogenic activity |
| 03/07/1992 | WO1992004346A1 Antimuscarinic bronchodilators |
| 03/05/1992 | WO1992004351A1 Certain cycloalkyl imidazopyrimidines, a new class of gaba brain receptor ligands |
| 03/05/1992 | WO1992003474A1 METHOD OF INTERFERING WITH FORMATION OF α-ANTICHYMOTRYPSIN-β-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
| 03/05/1992 | WO1992003435A1 Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 03/05/1992 | WO1992003433A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | WO1992003431A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | WO1992003430A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | WO1992003420A1 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydroisoquinolines)] having neuroprotective properties |
| 03/05/1992 | WO1992003410A1 N-(mercaptoalkyl)ureas and carbamates |
| 03/05/1992 | WO1992003143A1 Central nervous system activator and appetizing food additive |
| 03/05/1992 | WO1992003137A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |